UNSPSC 85692123: Supplement left scapula with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left scapula with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PU637Z

UNSPSC 85692123 Supplement left scapula with autologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code describes a specific orthopedic surgical procedure, yet the recent opportunities posted under this code span inmate medical and pharmacy services, pharmacy benefit management for county employees, virtual primary care and urgent care services, peer support services for mental health workers, and fire department medical direction — none of which involve orthopedic surgical procedures or scapular reconstruction. The mismatch suggests either a cataloging error in the source data or that state and local purchasing offices are applying this code to health services and medical administration work that does not align with the code's nominal scope.

The geographic and issuing-body mix in the recent opportunities reflects county and municipal health procurement activity in Florida, Georgia, and California, including the Muscogee County Prison (Georgia), Collier County (Florida), Monroe County (Florida), San Mateo County (California), and the Santa Monica Fire Department (California). However, because these opportunities do not represent actual purchasing under the code's defined scope, they do not establish meaningful market signals for orthopedic surgical products or services. Prospective vendors should verify directly with state and local procurement offices whether this code is the correct classification for their offerings before investing in pursuit strategy.